Literature DB >> 23458972

Neuroimmunology: Treatment of anti-NMDA receptor encephalitis--time to be bold?

Jessica A Panzer1, David R Lynch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23458972     DOI： 10.1038/nrneurol.2013.31

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.

Authors:  Ethan G Hughes; Xiaoyu Peng; Amy J Gleichman; Meizan Lai; Lei Zhou; Ryan Tsou; Thomas D Parsons; David R Lynch; Josep Dalmau; Rita J Balice-Gordon
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.

Authors:  Mary S Gable; Heather Sheriff; Josep Dalmau; Drake H Tilley; Carol A Glaser
Journal:  Clin Infect Dis       Date:  2012-01-26       Impact factor: 9.079

3.  Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.

Authors:  Qing Zhang; Keiko Tanaka; Peng Sun; Michiyo Nakata; Ryo Yamamoto; Kenji Sakimura; Makoto Matsui; Nobuo Kato
Journal:  Neurobiol Dis       Date:  2011-10-08       Impact factor: 5.996

4.  Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.

Authors:  Amy J Gleichman; Lynn A Spruce; Josep Dalmau; Steven H Seeholzer; David R Lynch
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

5.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 6.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

7.  Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.

Authors:  Julia Granerod; Helen E Ambrose; Nicholas Ws Davies; Jonathan P Clewley; Amanda L Walsh; Dilys Morgan; Richard Cunningham; Mark Zuckerman; Ken J Mutton; Tom Solomon; Katherine N Ward; Michael Pt Lunn; Sarosh R Irani; Angela Vincent; David Wg Brown; Natasha S Crowcroft
Journal:  Lancet Infect Dis       Date:  2010-10-15       Impact factor: 25.071

8.  Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

Authors:  Joseph C Masdeu; Ana González-Pinto; Carlos Matute; Sonia Ruiz De Azúa; A Palomino; Jose De Leon; Karen F Berman; Josep Dalmau
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

9.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

10.  Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.

Authors:  Andreas van Baalen; Martin Häusler; Barbara Plecko-Startinig; Jurgis Strautmanis; Stefan Vlaho; Boris Gebhardt; Axel Rohr; Angela Abicht; Gerhard Kluger; Ulrich Stephani; Christian Probst; Angela Vincent; Christian G Bien
Journal:  Neuropediatrics       Date:  2012-08-21       Impact factor: 1.947
  10 in total
  3 in total

1.  Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.

Authors:  Natasha Warikoo; Samuel J Brunwasser; Ann Benz; Hong-Jin Shu; Steven M Paul; Michael Lewis; James Doherty; Michael Quirk; Laura Piccio; Charles F Zorumski; Gregory S Day; Steven Mennerick
Journal:  J Neurosci       Date:  2018-02-23       Impact factor: 6.167

2.  Anti-N-Methyl-d-Aspartate Receptor Encephalitis in a Patient with Alcoholism: A Rare Case Report.

Authors:  Yangyang Li; Qiuling Wang; Chuanxin Liu; Yili Wu
Journal:  Front Psychiatry       Date:  2017-08-03       Impact factor: 4.157

Review 3.  Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.

Authors:  Cai-Yun Liu; Jie Zhu; Xiang-Yu Zheng; Chi Ma; Xu Wang
Journal:  Mediators Inflamm       Date:  2017-06-18       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.